Market Overview

Piper Jaffray Initiates Coverage on Galena Biopharma, Inc. at Overweight, Announces $2.50 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for GALE

DateFirmActionFromTo
Feb 2017FBR CapitalDowngradesOutperformMarket Weight
Feb 2017Maxim GroupDowngradesBuyHold
Jun 2016Raymond JamesDowngradesOutperformMarket Perform

View More Analyst Ratings for GALE
View the Latest Analyst Ratings

Posted-In: News Initiation Analyst Ratings

 

Related Articles (GALE)

Partner Center